Now showing items 1-6 of 6

• CD47 IS A NOVEL TARGET FOR CANCER IMMUNOTHERAPY TREATMENT
  2022
• THE DEVELOPMENT OF SELECTIVE PHOTOSENSITIZERS TO TARGET PATHOGENIC T CELLS AND PREVENT GRAFT-VERSUS-HOST DISEASE
  2017
• IMMUNO-REACTIVE CANCER ORGANOID MODELS TO EXAMINE MICROBIOME METABOLITE EFFECTS ON IMMUNE CHECKPOINT BLOCKADE EFFICACY
  2022
• MANIPULATING THE MICROBIOME TO ENHANCE ICB RESPONSIVENESS AND IMPROVE BREAST CANCER OUTCOMES
  2025
• MODULATION OF THE IMMUNE RESPONSE AS A POTENTIAL THERAPEUTIC FOR GLIOBLASTOMA
  2022
• The Usage of Clinicogenomics in Predicting Outcomes in Immunotherapy in Non-Small Cell Lung Cancer
  2024